Von dem Buch Clinical Documents for Drugs and Biologics haben wir 2 gleiche oder sehr ähnliche Ausgaben identifiziert!
Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:
100%: Targeted Regulatory Writing Techniques: Clinical Documents for Drugs and Biologics (ISBN: 9783764383626) 2009, in Englisch, auch als eBook.Nur diese Ausgabe anzeigen…
62%: Linda Fossati Wood (Editor), MaryAnn Foote (Editor): Targeted Regulatory Writing Techniques: Clinical Documents for Drugs and Biologics (Paperback) (ISBN: 9783764383619) in Deutsch, Taschenbuch.Nur diese Ausgabe anzeigen…
Clinical Documents for Drugs and Biologics - 13 Angebote vergleichen
| Preise | 2013 | 2014 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Schnitt | € 52,52 | € 54,76 | € 51,84 | € 63,06 | € 43,70 |
| Nachfrage |
1
Targeted Regulatory Writing Techniques: Clinical Documents for Drugs and Biologics
~EN NW EB DLISBN: 9783764383626 bzw. 3764383623, vermutlich in Englisch, Springer Shop, neu, E-Book, elektronischer Download.
Lieferung aus: Japan, Lagernd, zzgl. Versandkosten.
This book describes the authors’ standard or ‘best’ practices used in writing regul- ed clinical documents for the drug and biologics industry. The fundamental premise of this book is that the end (documents submitted to a health authority) is dep- dent on the beginning (the planning and strategy that go into organizing written documentation). Each regulatory document inherently exists within a constellation of related documents. This book attempts to show the relationships between and among these documents and suggests strategies for organizing and writing these documents to maximize ef?ciency while developing clear and concise text. At all times, and irrespective of applicable laws and guidelines, good communication skills and a sense of balance are essential to adequately, accurately, and clearly describe a product’s characteristics. At no time should the reader perceive these suggestions to be the only viable solution to writing regulatory documents nor should the reader expect that these suggestions guarantee product success. The audience for this book is the novice medical writer, or those who would like to explore or enhance regulatory-writing skills. We assume the reader will have a basic understanding of written communication, but little experience in applying this skill to the task of regulatory writing. Extensive knowledge of science, clinical me- cine, mathematics, or regulatory affairs law is not required to use the best practices described in this book. eBook.
This book describes the authors’ standard or ‘best’ practices used in writing regul- ed clinical documents for the drug and biologics industry. The fundamental premise of this book is that the end (documents submitted to a health authority) is dep- dent on the beginning (the planning and strategy that go into organizing written documentation). Each regulatory document inherently exists within a constellation of related documents. This book attempts to show the relationships between and among these documents and suggests strategies for organizing and writing these documents to maximize ef?ciency while developing clear and concise text. At all times, and irrespective of applicable laws and guidelines, good communication skills and a sense of balance are essential to adequately, accurately, and clearly describe a product’s characteristics. At no time should the reader perceive these suggestions to be the only viable solution to writing regulatory documents nor should the reader expect that these suggestions guarantee product success. The audience for this book is the novice medical writer, or those who would like to explore or enhance regulatory-writing skills. We assume the reader will have a basic understanding of written communication, but little experience in applying this skill to the task of regulatory writing. Extensive knowledge of science, clinical me- cine, mathematics, or regulatory affairs law is not required to use the best practices described in this book. eBook.
2
Targeted Regulatory Writing Techniques: Clinical Documents for Drugs and Biologics (2009)
DE NW EB DLISBN: 9783764383626 bzw. 3764383623, in Deutsch, Birkenhäuser Verlag, Basel/Boston/Stuttgart, Schweiz, neu, E-Book, elektronischer Download.
Lieferung aus: Deutschland, Versandkostenfrei, Download.
This book describes the authors’ standard or ‘best’ practices used in writing regul- ed clinical documents for the drug and biologics industry. The fundamental premise of this book is that the end (documents submitted to a health authority) is dep- dent on the beginning (the planning and strategy that go into organizing written documentation). Each regulatory document inherently exists within a constellation of related documents. This book attempts to show the relationships between and among these documents and suggests strategies for organizing and writing these documents to maximize ef?ciency while developing clear and concise text. At all times, and irrespective of applicable laws and guidelines, good communication skills and a sense of balance are essential to adequately, accurately, and clearly describe a product’s characteristics. At no time should the reader perceive these suggestions to be the only viable solution to writing regulatory documents nor should the reader expect that these suggestions guarantee product success. The audience for this book is the novice medical writer, or those who would like to explore or enhance regulatory-writing skills. We assume the reader will have a basic understanding of written communication, but little experience in applying this skill to the task of regulatory writing. Extensive knowledge of science, clinical me- cine, mathematics, or regulatory affairs law is not required to use the best practices described in this book.
This book describes the authors’ standard or ‘best’ practices used in writing regul- ed clinical documents for the drug and biologics industry. The fundamental premise of this book is that the end (documents submitted to a health authority) is dep- dent on the beginning (the planning and strategy that go into organizing written documentation). Each regulatory document inherently exists within a constellation of related documents. This book attempts to show the relationships between and among these documents and suggests strategies for organizing and writing these documents to maximize ef?ciency while developing clear and concise text. At all times, and irrespective of applicable laws and guidelines, good communication skills and a sense of balance are essential to adequately, accurately, and clearly describe a product’s characteristics. At no time should the reader perceive these suggestions to be the only viable solution to writing regulatory documents nor should the reader expect that these suggestions guarantee product success. The audience for this book is the novice medical writer, or those who would like to explore or enhance regulatory-writing skills. We assume the reader will have a basic understanding of written communication, but little experience in applying this skill to the task of regulatory writing. Extensive knowledge of science, clinical me- cine, mathematics, or regulatory affairs law is not required to use the best practices described in this book.
3
Targeted Regulatory Writing Techniques: Clinical Documents for Drugs and Biologics
DE PB NWISBN: 9783764383619 bzw. 3764383615, in Deutsch, Birkhäuser, Taschenbuch, neu.
Von Händler/Antiquariat, BuySomeBooks [52360437], Las Vegas, NV, U.S.A.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
4
Targeted Regulatory Writing Techniques Clinical Documents for Drugs and Biologics (u. a.) Taschenbuch Book Englisch 2008 (2008)
~DE PB NWISBN: 9783764383619 bzw. 3764383615, vermutlich in Deutsch, 237 Seiten, Springer Basel, Taschenbuch, neu.
Lieferung aus: Deutschland, Gratis verzending.
Von Händler/Antiquariat, preigu, [5789586].
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Von Händler/Antiquariat, preigu, [5789586].
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
5
Targeted Regulatory Writing Techniques: Clinical Documents for Drugs and Biologics (Paperback) (2009)
DE PB NW RPISBN: 9783764383619 bzw. 3764383615, in Deutsch, Birkhauser Verlag AG, Switzerland, Taschenbuch, neu, Nachdruck.
Lieferung aus: Vereinigtes Königreich Großbritannien und Nordirland, Versandkostenfrei.
Von Händler/Antiquariat, The Book Depository EURO [60485773], London, United Kingdom.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Von Händler/Antiquariat, The Book Depository EURO [60485773], London, United Kingdom.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
6
Targeted Regulatory Writing Techniques (2008)
DE PB NWISBN: 9783764383619 bzw. 3764383615, in Deutsch, Springer Basel Ag Nov 2008, Taschenbuch, neu.
Von Händler/Antiquariat, Agrios-Buch [57449362], Bergisch Gladbach, NRW, Germany.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
7
Targeted Regulatory Writing Techniques (2014)
DE PB NWISBN: 9783764383619 bzw. 3764383615, in Deutsch, Springer Basel AG, Taschenbuch, neu.
Lieferung aus: Deutschland, Versandkostenfrei.
Carl Hübscher GmbH, [4514147].
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Carl Hübscher GmbH, [4514147].
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
9
Targeted Regulatory Writing Techniques: Clinical Documents for Drugs and Biologics
DE NW EB DLISBN: 9783764383626 bzw. 3764383623, in Deutsch, Springer Basel, neu, E-Book, elektronischer Download.
Lieferung aus: Deutschland, Versandkostenfrei.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
10
Clinical Documents for Drugs and Biologics als eBook von
DE NW EB DLISBN: 9783764383626 bzw. 3764383623, in Deutsch, Birkenhäuser Verlag, Basel/Boston/Stuttgart, Schweiz, neu, E-Book, elektronischer Download.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Lade…